Project
avrg: Illumina Body Map 2 (GSE30611)
Navigation
Downloads
Results for SMAD1
Z-value: 3.29
Motif logo
Transcription factors associated with SMAD1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
SMAD1
|
ENSG00000170365.10 | SMAD1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SMAD1 | hg38_v1_chr4_+_145481691_145481712 | -0.42 | 1.8e-02 | Click! |
Activity profile of SMAD1 motif
Sorted Z-values of SMAD1 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of SMAD1
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr14_-_105771405 | 12.94 |
ENST00000641136.1
ENST00000390551.6 |
IGHG3
|
immunoglobulin heavy constant gamma 3 (G3m marker) |
| chr14_-_105644790 | 9.84 |
ENST00000641095.1
ENST00000390545.3 |
IGHG2
|
immunoglobulin heavy constant gamma 2 (G2m marker) |
| chr2_+_101991953 | 9.56 |
ENST00000332549.8
|
IL1R2
|
interleukin 1 receptor type 2 |
| chr14_-_105626066 | 9.28 |
ENST00000641978.1
ENST00000390543.3 |
IGHG4
|
immunoglobulin heavy constant gamma 4 (G4m marker) |
| chr19_+_49335396 | 9.15 |
ENST00000598095.5
ENST00000426897.6 ENST00000323906.9 ENST00000535669.6 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
| chr22_+_22895368 | 7.92 |
ENST00000390321.2
|
IGLC1
|
immunoglobulin lambda constant 1 |
| chr6_-_31582415 | 7.62 |
ENST00000429299.3
ENST00000446745.2 |
LTB
|
lymphotoxin beta |
| chr16_+_30472733 | 7.14 |
ENST00000356798.11
ENST00000433423.2 |
ITGAL
|
integrin subunit alpha L |
| chr22_+_22686724 | 6.76 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
| chr16_-_29745951 | 6.53 |
ENST00000329410.4
|
C16orf54
|
chromosome 16 open reading frame 54 |
| chr14_-_105743032 | 6.05 |
ENST00000390548.6
ENST00000390549.6 ENST00000390542.6 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr19_+_18173148 | 5.95 |
ENST00000597802.2
|
IFI30
|
IFI30 lysosomal thiol reductase |
| chr2_-_89143133 | 5.89 |
ENST00000492167.1
|
IGKV3-20
|
immunoglobulin kappa variable 3-20 |
| chr14_-_105856183 | 5.88 |
ENST00000637539.2
ENST00000390559.6 |
IGHM
|
immunoglobulin heavy constant mu |
| chr1_-_161631152 | 5.85 |
ENST00000421702.3
ENST00000650385.1 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
| chr17_-_82317523 | 5.72 |
ENST00000583376.1
ENST00000578509.1 ENST00000584284.5 ENST00000582480.1 |
CD7
|
CD7 molecule |
| chr14_-_105708627 | 5.70 |
ENST00000641837.1
ENST00000390547.3 |
IGHA1
|
immunoglobulin heavy constant alpha 1 |
| chr14_-_106715166 | 5.67 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
| chr19_-_51630401 | 5.65 |
ENST00000683636.1
|
SIGLEC5
|
sialic acid binding Ig like lectin 5 |
| chr16_+_3065348 | 5.63 |
ENST00000529699.5
ENST00000526464.6 ENST00000440815.7 ENST00000529550.5 |
IL32
|
interleukin 32 |
| chr12_-_108633864 | 5.57 |
ENST00000550948.2
|
SELPLG
|
selectin P ligand |
| chr19_+_41877267 | 5.55 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79A
|
CD79a molecule |
| chr16_+_3065311 | 5.47 |
ENST00000534507.5
ENST00000613483.4 ENST00000531965.5 ENST00000396887.7 |
IL32
|
interleukin 32 |
| chr16_+_3065297 | 5.44 |
ENST00000325568.9
|
IL32
|
interleukin 32 |
| chr17_-_82317589 | 5.41 |
ENST00000312648.8
|
CD7
|
CD7 molecule |
| chr22_+_22720615 | 5.29 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
| chr14_-_94390667 | 5.28 |
ENST00000557492.5
ENST00000355814.8 ENST00000437397.5 ENST00000448921.5 ENST00000393088.8 |
SERPINA1
|
serpin family A member 1 |
| chr19_-_51372269 | 5.23 |
ENST00000593572.5
ENST00000595157.1 |
NKG7
|
natural killer cell granule protein 7 |
| chr14_-_106422175 | 5.21 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
| chr14_-_94390650 | 5.20 |
ENST00000449399.7
ENST00000404814.8 |
SERPINA1
|
serpin family A member 1 |
| chr7_+_142352802 | 5.18 |
ENST00000634605.1
|
TRBV7-2
|
T cell receptor beta variable 7-2 |
| chr2_-_88992903 | 5.16 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chrX_+_1268828 | 5.12 |
ENST00000432318.8
ENST00000381509.8 ENST00000494969.7 ENST00000355805.7 ENST00000355432.8 |
CSF2RA
|
colony stimulating factor 2 receptor subunit alpha |
| chr16_+_3065380 | 5.10 |
ENST00000551122.5
ENST00000548807.5 ENST00000528163.6 |
IL32
|
interleukin 32 |
| chr22_+_22375984 | 4.85 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
| chr22_+_22697789 | 4.85 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr7_+_142529268 | 4.81 |
ENST00000612787.1
|
TRBV7-9
|
T cell receptor beta variable 7-9 |
| chr2_+_90038848 | 4.80 |
ENST00000390270.2
|
IGKV3D-20
|
immunoglobulin kappa variable 3D-20 |
| chr14_-_94390614 | 4.68 |
ENST00000553327.5
ENST00000556955.5 ENST00000557118.5 ENST00000440909.5 |
SERPINA1
|
serpin family A member 1 |
| chr11_-_2301859 | 4.60 |
ENST00000456145.2
ENST00000381153.8 |
C11orf21
|
chromosome 11 open reading frame 21 |
| chr16_+_3065610 | 4.58 |
ENST00000530890.5
ENST00000444393.7 ENST00000533097.6 ENST00000008180.13 ENST00000396890.6 ENST00000525228.5 ENST00000525643.7 ENST00000548652.5 ENST00000525377.6 ENST00000530538.6 ENST00000549213.5 ENST00000552936.5 ENST00000548476.5 ENST00000552664.5 ENST00000552356.5 ENST00000551513.5 ENST00000382213.7 ENST00000548246.1 |
IL32
|
interleukin 32 |
| chr22_+_22887780 | 4.57 |
ENST00000532223.2
ENST00000526893.6 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda like polypeptide 5 |
| chr14_+_22547495 | 4.53 |
ENST00000611116.2
|
TRAC
|
T cell receptor alpha constant |
| chr22_-_37149900 | 4.53 |
ENST00000216223.10
|
IL2RB
|
interleukin 2 receptor subunit beta |
| chr5_+_55102635 | 4.51 |
ENST00000274306.7
|
GZMA
|
granzyme A |
| chr2_+_89862438 | 4.48 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr2_+_90172802 | 4.46 |
ENST00000390277.3
|
IGKV3D-11
|
immunoglobulin kappa variable 3D-11 |
| chr19_+_18173804 | 4.46 |
ENST00000407280.4
|
IFI30
|
IFI30 lysosomal thiol reductase |
| chr7_+_142462882 | 4.44 |
ENST00000454561.2
|
TRBV5-4
|
T cell receptor beta variable 5-4 |
| chr4_-_154612635 | 4.42 |
ENST00000407946.5
ENST00000405164.5 ENST00000336098.8 ENST00000393846.6 ENST00000404648.7 ENST00000443553.5 |
FGG
|
fibrinogen gamma chain |
| chr22_+_22734577 | 4.40 |
ENST00000390310.3
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
| chr7_-_38363476 | 4.39 |
ENST00000426402.2
|
TRGV2
|
T cell receptor gamma variable 2 |
| chr19_+_51142299 | 4.34 |
ENST00000601682.1
ENST00000317643.10 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig like lectin 7 |
| chr9_-_37034261 | 4.30 |
ENST00000358127.9
ENST00000377852.7 ENST00000523241.6 |
PAX5
|
paired box 5 |
| chr22_+_22792485 | 4.26 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr22_+_22431949 | 4.25 |
ENST00000390301.3
|
IGLV1-36
|
immunoglobulin lambda variable 1-36 |
| chr16_+_30472700 | 4.21 |
ENST00000358164.9
|
ITGAL
|
integrin subunit alpha L |
| chr7_+_142320677 | 4.19 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
| chr22_+_22322452 | 4.16 |
ENST00000390290.3
|
IGLV1-51
|
immunoglobulin lambda variable 1-51 |
| chr14_-_106762576 | 4.14 |
ENST00000624687.1
|
IGHV1-69D
|
immunoglobulin heavy variable 1-69D |
| chr6_+_31615984 | 4.14 |
ENST00000376049.4
|
AIF1
|
allograft inflammatory factor 1 |
| chr2_+_102008515 | 4.14 |
ENST00000441002.1
|
IL1R2
|
interleukin 1 receptor type 2 |
| chr6_-_31272069 | 4.12 |
ENST00000415537.1
ENST00000376228.9 ENST00000383329.7 |
HLA-C
|
major histocompatibility complex, class I, C |
| chr15_-_21718245 | 4.08 |
ENST00000630556.1
|
ENSG00000281179.1
|
novel gene identicle to IGHV1OR15-1 |
| chr1_-_161631032 | 4.06 |
ENST00000534776.1
ENST00000613418.4 ENST00000614870.4 |
FCGR3B
|
Fc fragment of IgG receptor IIIb |
| chr22_+_22098683 | 4.06 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
| chr7_+_142391884 | 4.04 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
| chr21_-_44910630 | 4.04 |
ENST00000320216.10
ENST00000397852.5 |
ITGB2
|
integrin subunit beta 2 |
| chr1_+_32274111 | 4.02 |
ENST00000619559.4
ENST00000461712.6 ENST00000373562.7 ENST00000477031.6 ENST00000373557.6 ENST00000333070.4 |
LCK
|
LCK proto-oncogene, Src family tyrosine kinase |
| chr2_-_86790825 | 3.96 |
ENST00000409781.1
ENST00000352580.7 |
CD8A
|
CD8a molecule |
| chr1_+_207454230 | 3.95 |
ENST00000367058.7
ENST00000367059.3 ENST00000367057.8 |
CR2
|
complement C3d receptor 2 |
| chr6_-_33080767 | 3.93 |
ENST00000453337.1
ENST00000417724.1 |
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
| chr11_+_1870871 | 3.92 |
ENST00000417766.5
|
LSP1
|
lymphocyte specific protein 1 |
| chr14_-_106639589 | 3.92 |
ENST00000390630.3
|
IGHV4-61
|
immunoglobulin heavy variable 4-61 |
| chr22_+_22880706 | 3.90 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
| chr2_-_89160329 | 3.89 |
ENST00000390256.2
|
IGKV6-21
|
immunoglobulin kappa variable 6-21 (non-functional) |
| chr2_+_97713568 | 3.89 |
ENST00000264972.10
|
ZAP70
|
zeta chain of T cell receptor associated protein kinase 70 |
| chr1_+_40373697 | 3.88 |
ENST00000372718.8
|
SMAP2
|
small ArfGAP2 |
| chr6_+_33080445 | 3.87 |
ENST00000428835.5
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
| chr16_+_30182795 | 3.86 |
ENST00000563778.5
|
CORO1A
|
coronin 1A |
| chr15_+_81299416 | 3.85 |
ENST00000558332.3
|
IL16
|
interleukin 16 |
| chr4_+_77605807 | 3.84 |
ENST00000682537.1
|
CXCL13
|
C-X-C motif chemokine ligand 13 |
| chr22_+_22162155 | 3.83 |
ENST00000390284.2
|
IGLV4-60
|
immunoglobulin lambda variable 4-60 |
| chr10_-_133276836 | 3.81 |
ENST00000415217.7
|
ADAM8
|
ADAM metallopeptidase domain 8 |
| chr1_-_157820060 | 3.81 |
ENST00000491942.1
ENST00000358292.7 |
FCRL1
|
Fc receptor like 1 |
| chr6_-_32816910 | 3.79 |
ENST00000447394.1
ENST00000438763.7 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
| chr1_-_160862880 | 3.77 |
ENST00000368034.9
|
CD244
|
CD244 molecule |
| chr22_+_22758698 | 3.77 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr14_-_106277039 | 3.76 |
ENST00000390610.2
|
IGHV1-24
|
immunoglobulin heavy variable 1-24 |
| chr19_+_40586774 | 3.75 |
ENST00000594298.5
ENST00000597396.5 |
SHKBP1
|
SH3KBP1 binding protein 1 |
| chr2_-_89040745 | 3.73 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr2_-_89010515 | 3.72 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr19_+_44751251 | 3.72 |
ENST00000444487.1
|
BCL3
|
BCL3 transcription coactivator |
| chr6_+_31587268 | 3.71 |
ENST00000396101.7
ENST00000490742.5 |
LST1
|
leukocyte specific transcript 1 |
| chr1_-_28176665 | 3.70 |
ENST00000373857.8
|
PTAFR
|
platelet activating factor receptor |
| chr22_-_41926791 | 3.69 |
ENST00000291232.5
|
TNFRSF13C
|
TNF receptor superfamily member 13C |
| chr19_+_15641280 | 3.68 |
ENST00000585846.1
|
CYP4F3
|
cytochrome P450 family 4 subfamily F member 3 |
| chr1_+_27879638 | 3.68 |
ENST00000456990.1
|
THEMIS2
|
thymocyte selection associated family member 2 |
| chr22_+_22409755 | 3.67 |
ENST00000390299.2
|
IGLV1-40
|
immunoglobulin lambda variable 1-40 |
| chr1_-_36482904 | 3.67 |
ENST00000373106.6
|
CSF3R
|
colony stimulating factor 3 receptor |
| chr14_-_24609660 | 3.66 |
ENST00000557220.6
ENST00000216338.9 ENST00000382548.4 |
GZMH
|
granzyme H |
| chr7_+_142618821 | 3.65 |
ENST00000390393.3
|
TRBV19
|
T cell receptor beta variable 19 |
| chr19_-_54280498 | 3.65 |
ENST00000391746.5
|
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
| chr17_-_63701140 | 3.63 |
ENST00000584645.1
|
LIMD2
|
LIM domain containing 2 |
| chr22_+_22822658 | 3.62 |
ENST00000620395.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr14_-_106269133 | 3.60 |
ENST00000390609.3
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr11_+_1864172 | 3.59 |
ENST00000446808.5
ENST00000509204.1 |
LSP1
ENSG00000249086.1
|
lymphocyte specific protein 1 novel transcript, sense overlapping LSP1 |
| chr14_-_106154113 | 3.59 |
ENST00000390603.2
|
IGHV3-15
|
immunoglobulin heavy variable 3-15 |
| chr22_+_22395005 | 3.58 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
| chr14_-_95714114 | 3.58 |
ENST00000402399.6
ENST00000555202.1 |
TCL1A
|
TCL1 family AKT coactivator A |
| chr19_-_51372640 | 3.57 |
ENST00000600427.5
ENST00000221978.10 |
NKG7
|
natural killer cell granule protein 7 |
| chr5_+_136049513 | 3.56 |
ENST00000514554.5
|
TGFBI
|
transforming growth factor beta induced |
| chr1_-_157820113 | 3.55 |
ENST00000368176.8
|
FCRL1
|
Fc receptor like 1 |
| chr11_-_118225086 | 3.53 |
ENST00000640745.1
|
JAML
|
junction adhesion molecule like |
| chr16_+_28985251 | 3.45 |
ENST00000360872.9
ENST00000566177.5 |
LAT
|
linker for activation of T cells |
| chr14_-_106301848 | 3.44 |
ENST00000390611.2
|
IGHV2-26
|
immunoglobulin heavy variable 2-26 |
| chr2_-_86790900 | 3.43 |
ENST00000283635.8
|
CD8A
|
CD8a molecule |
| chr12_+_6789508 | 3.43 |
ENST00000011653.9
ENST00000541982.5 ENST00000539492.1 |
CD4
|
CD4 molecule |
| chr19_+_1067493 | 3.42 |
ENST00000586866.5
|
ARHGAP45
|
Rho GTPase activating protein 45 |
| chr19_-_11577632 | 3.41 |
ENST00000590420.1
ENST00000648477.1 |
ACP5
|
acid phosphatase 5, tartrate resistant |
| chr14_-_106185387 | 3.36 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr5_+_76716094 | 3.36 |
ENST00000319211.5
|
F2R
|
coagulation factor II thrombin receptor |
| chr22_+_22343185 | 3.35 |
ENST00000427632.2
|
IGLV9-49
|
immunoglobulin lambda variable 9-49 |
| chr19_-_42528380 | 3.32 |
ENST00000403461.5
ENST00000352591.9 ENST00000358394.7 ENST00000403444.7 ENST00000161559.11 ENST00000599389.1 |
CEACAM1
|
CEA cell adhesion molecule 1 |
| chr10_-_133276855 | 3.31 |
ENST00000486609.1
ENST00000445355.8 ENST00000485491.6 |
ADAM8
|
ADAM metallopeptidase domain 8 |
| chr19_-_54281145 | 3.29 |
ENST00000434421.5
ENST00000391749.4 |
LILRB2
|
leukocyte immunoglobulin like receptor B2 |
| chr1_-_56966133 | 3.28 |
ENST00000535057.5
ENST00000543257.5 |
C8B
|
complement C8 beta chain |
| chr7_+_74209386 | 3.27 |
ENST00000344995.9
|
LAT2
|
linker for activation of T cells family member 2 |
| chr13_+_108269629 | 3.27 |
ENST00000430559.5
ENST00000375887.9 |
TNFSF13B
|
TNF superfamily member 13b |
| chr2_-_181657096 | 3.25 |
ENST00000410087.8
ENST00000409440.7 |
CERKL
|
ceramide kinase like |
| chr22_+_22327298 | 3.25 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr19_+_54573781 | 3.24 |
ENST00000391738.8
ENST00000251376.7 ENST00000391737.3 ENST00000629481.1 |
LILRA2
|
leukocyte immunoglobulin like receptor A2 |
| chr22_+_36863091 | 3.24 |
ENST00000650698.1
|
NCF4
|
neutrophil cytosolic factor 4 |
| chr7_+_74209989 | 3.23 |
ENST00000361082.7
ENST00000275635.11 ENST00000460943.6 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family member 2 |
| chr19_-_51646800 | 3.22 |
ENST00000599649.5
ENST00000429354.3 ENST00000360844.6 |
SIGLEC5
SIGLEC14
|
sialic acid binding Ig like lectin 5 sialic acid binding Ig like lectin 14 |
| chr14_-_106811131 | 3.20 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr12_+_6946468 | 3.19 |
ENST00000543115.5
ENST00000399448.5 |
PTPN6
|
protein tyrosine phosphatase non-receptor type 6 |
| chr5_+_169695135 | 3.16 |
ENST00000523684.5
ENST00000519734.5 |
DOCK2
|
dedicator of cytokinesis 2 |
| chr19_-_51372686 | 3.16 |
ENST00000595217.1
|
NKG7
|
natural killer cell granule protein 7 |
| chr14_+_21868822 | 3.15 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
| chr9_-_137032081 | 3.14 |
ENST00000314412.7
|
FUT7
|
fucosyltransferase 7 |
| chr14_-_95714146 | 3.13 |
ENST00000554012.5
|
TCL1A
|
TCL1 family AKT coactivator A |
| chr2_+_68365274 | 3.13 |
ENST00000234313.8
|
PLEK
|
pleckstrin |
| chr22_+_22904850 | 3.11 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr16_+_31355215 | 3.11 |
ENST00000562522.2
|
ITGAX
|
integrin subunit alpha X |
| chr12_-_56957587 | 3.09 |
ENST00000398138.5
|
RDH16
|
retinol dehydrogenase 16 |
| chr1_-_160862700 | 3.08 |
ENST00000322302.7
ENST00000368033.7 |
CD244
|
CD244 molecule |
| chr19_+_15640880 | 3.07 |
ENST00000586182.6
ENST00000221307.13 ENST00000591058.5 |
CYP4F3
|
cytochrome P450 family 4 subfamily F member 3 |
| chr2_+_89851723 | 3.06 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
| chr14_+_103121457 | 3.06 |
ENST00000333007.8
|
TNFAIP2
|
TNF alpha induced protein 2 |
| chr9_-_134917872 | 3.06 |
ENST00000616356.4
ENST00000371806.4 |
FCN1
|
ficolin 1 |
| chr2_-_89268506 | 3.05 |
ENST00000473726.1
|
IGKV1-33
|
immunoglobulin kappa variable 1-33 |
| chr10_+_45374204 | 3.05 |
ENST00000374391.7
|
ALOX5
|
arachidonate 5-lipoxygenase |
| chr14_-_106511856 | 3.03 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr12_-_7128873 | 3.03 |
ENST00000542370.1
ENST00000266560.8 |
RBP5
|
retinol binding protein 5 |
| chr20_-_1657762 | 3.02 |
ENST00000303415.7
ENST00000381583.6 |
SIRPG
|
signal regulatory protein gamma |
| chr14_-_106088573 | 2.99 |
ENST00000632099.1
|
IGHV3-64D
|
immunoglobulin heavy variable 3-64D |
| chr9_-_35618367 | 2.99 |
ENST00000378431.5
ENST00000378430.3 ENST00000259633.9 |
CD72
|
CD72 molecule |
| chr22_+_39960397 | 2.99 |
ENST00000424496.2
|
ENSG00000225528.3
|
novel protein similar to translation machinery associated 7 homolog (S. cerevisiae) TMA7 |
| chr11_+_65879791 | 2.99 |
ENST00000528419.6
ENST00000307886.8 ENST00000526034.2 ENST00000679584.1 ENST00000680443.1 ENST00000680670.1 |
CTSW
|
cathepsin W |
| chr3_+_52787825 | 2.96 |
ENST00000405128.3
|
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1 |
| chr11_+_2301987 | 2.96 |
ENST00000612299.4
ENST00000182290.9 |
TSPAN32
|
tetraspanin 32 |
| chr3_+_52794768 | 2.95 |
ENST00000621946.4
ENST00000416872.6 ENST00000449956.2 |
ITIH3
|
inter-alpha-trypsin inhibitor heavy chain 3 |
| chr11_+_1870252 | 2.94 |
ENST00000612798.4
|
LSP1
|
lymphocyte specific protein 1 |
| chr2_+_87338511 | 2.91 |
ENST00000421835.2
|
IGKV3OR2-268
|
immunoglobulin kappa variable 3/OR2-268 (non-functional) |
| chr1_-_169711603 | 2.89 |
ENST00000236147.6
ENST00000650983.1 |
SELL
|
selectin L |
| chr16_-_88703611 | 2.88 |
ENST00000541206.6
|
RNF166
|
ring finger protein 166 |
| chr12_+_6951345 | 2.88 |
ENST00000318974.14
ENST00000541698.5 ENST00000542462.1 |
PTPN6
|
protein tyrosine phosphatase non-receptor type 6 |
| chr6_+_31586835 | 2.87 |
ENST00000211921.11
|
LST1
|
leukocyte specific transcript 1 |
| chr11_-_67437670 | 2.87 |
ENST00000326294.4
|
PTPRCAP
|
protein tyrosine phosphatase receptor type C associated protein |
| chr1_-_202159977 | 2.87 |
ENST00000367279.8
|
PTPN7
|
protein tyrosine phosphatase non-receptor type 7 |
| chr4_-_1172575 | 2.85 |
ENST00000290902.10
|
SPON2
|
spondin 2 |
| chr19_+_1067144 | 2.85 |
ENST00000313093.7
|
ARHGAP45
|
Rho GTPase activating protein 45 |
| chr2_+_90234809 | 2.84 |
ENST00000443397.5
|
IGKV3D-7
|
immunoglobulin kappa variable 3D-7 |
| chr22_+_22195753 | 2.83 |
ENST00000390285.4
|
IGLV6-57
|
immunoglobulin lambda variable 6-57 |
| chr2_-_89245596 | 2.82 |
ENST00000468494.1
|
IGKV2-30
|
immunoglobulin kappa variable 2-30 |
| chr14_-_91253925 | 2.81 |
ENST00000531499.2
|
GPR68
|
G protein-coupled receptor 68 |
| chr20_-_1657714 | 2.81 |
ENST00000216927.4
ENST00000344103.8 |
SIRPG
|
signal regulatory protein gamma |
| chr6_-_31357171 | 2.81 |
ENST00000412585.7
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
| chr15_-_21742799 | 2.80 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
| chr19_-_54222978 | 2.79 |
ENST00000245620.13
ENST00000346401.10 ENST00000445347.1 |
LILRB3
|
leukocyte immunoglobulin like receptor B3 |
| chr2_-_89320146 | 2.79 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
| chr14_-_105588322 | 2.78 |
ENST00000497872.4
ENST00000390539.2 |
IGHA2
|
immunoglobulin heavy constant alpha 2 (A2m marker) |
| chr9_+_114323098 | 2.78 |
ENST00000259396.9
|
ORM1
|
orosomucoid 1 |
| chr22_+_50545890 | 2.77 |
ENST00000648057.3
|
KLHDC7B
|
kelch domain containing 7B |
| chr7_+_142500027 | 2.76 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
| chr14_-_105940235 | 2.76 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr14_-_94388589 | 2.75 |
ENST00000402629.1
ENST00000556091.1 ENST00000393087.9 ENST00000554720.1 |
SERPINA1
|
serpin family A member 1 |
| chr16_+_28985095 | 2.73 |
ENST00000454369.6
|
LAT
|
linker for activation of T cells |
| chr7_+_100373458 | 2.73 |
ENST00000453419.5
ENST00000198536.7 ENST00000394000.6 ENST00000350573.2 |
PILRA
|
paired immunoglobin like type 2 receptor alpha |
| chr4_+_6693870 | 2.73 |
ENST00000296370.4
|
S100P
|
S100 calcium binding protein P |
| chr3_-_120682215 | 2.72 |
ENST00000283871.10
|
HGD
|
homogentisate 1,2-dioxygenase |
| chr15_+_81296913 | 2.72 |
ENST00000394652.6
|
IL16
|
interleukin 16 |
| chr14_-_95714088 | 2.72 |
ENST00000556450.5
|
TCL1A
|
TCL1 family AKT coactivator A |
| chr9_-_37034031 | 2.72 |
ENST00000520281.5
ENST00000446742.5 ENST00000522003.5 ENST00000523145.5 ENST00000414447.5 ENST00000377847.6 ENST00000377853.6 |
PAX5
|
paired box 5 |
| chr2_-_89117844 | 2.72 |
ENST00000490686.1
|
IGKV1-17
|
immunoglobulin kappa variable 1-17 |
| chr22_-_37244417 | 2.71 |
ENST00000405484.5
ENST00000441619.5 ENST00000406508.5 |
RAC2
|
Rac family small GTPase 2 |
| chr7_-_38349972 | 2.71 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
| chr6_+_29942523 | 2.70 |
ENST00000376809.10
ENST00000376802.2 ENST00000638375.1 |
HLA-A
|
major histocompatibility complex, class I, A |
| chr11_-_414948 | 2.70 |
ENST00000530494.1
ENST00000528209.5 ENST00000528058.1 ENST00000431843.7 |
SIGIRR
|
single Ig and TIR domain containing |
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.8 | 15.2 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 2.5 | 7.6 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
| 2.5 | 9.9 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
| 2.3 | 6.8 | GO:0071661 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 2.2 | 6.7 | GO:0002380 | immunoglobulin secretion involved in immune response(GO:0002380) |
| 2.0 | 5.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 2.0 | 7.8 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 1.9 | 5.7 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
| 1.9 | 14.9 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 1.8 | 11.1 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 1.7 | 5.1 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
| 1.7 | 6.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.6 | 1.6 | GO:0002351 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 1.6 | 6.5 | GO:2000753 | regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 1.6 | 8.1 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 1.6 | 140.3 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 1.6 | 15.5 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 1.5 | 1.5 | GO:0001810 | regulation of type I hypersensitivity(GO:0001810) type I hypersensitivity(GO:0016068) |
| 1.5 | 1.5 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 1.5 | 4.4 | GO:0099552 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 1.5 | 7.3 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 1.4 | 10.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.4 | 8.5 | GO:2001107 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 1.4 | 4.2 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
| 1.4 | 5.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 1.4 | 2.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 1.3 | 5.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.3 | 2.7 | GO:1905237 | response to cyclosporin A(GO:1905237) |
| 1.3 | 10.4 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 1.3 | 10.4 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 1.3 | 2.6 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
| 1.3 | 3.8 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.3 | 3.8 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 1.3 | 3.8 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 1.3 | 16.4 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 1.3 | 5.0 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 1.2 | 5.0 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.2 | 3.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 1.2 | 4.8 | GO:0090472 | viral protein processing(GO:0019082) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
| 1.2 | 3.6 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.2 | 1.2 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 1.2 | 4.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.1 | 3.4 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
| 1.1 | 129.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.1 | 4.4 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.1 | 1.1 | GO:0034125 | negative regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034125) |
| 1.1 | 5.3 | GO:0032796 | uropod organization(GO:0032796) |
| 1.1 | 3.2 | GO:0061011 | hepatic duct development(GO:0061011) |
| 1.1 | 5.3 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 1.1 | 3.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
| 1.0 | 4.1 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
| 1.0 | 6.0 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 1.0 | 4.0 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 1.0 | 10.8 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 1.0 | 3.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.0 | 3.9 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.0 | 2.9 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.9 | 2.8 | GO:0042309 | homoiothermy(GO:0042309) |
| 0.9 | 2.7 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.9 | 2.7 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.9 | 21.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.9 | 3.6 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 0.9 | 2.7 | GO:1902997 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.9 | 3.5 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.9 | 1.7 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.8 | 11.6 | GO:0008228 | opsonization(GO:0008228) |
| 0.8 | 7.4 | GO:0014900 | muscle hyperplasia(GO:0014900) |
| 0.8 | 3.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 0.8 | 3.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.8 | 2.3 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.8 | 2.3 | GO:1903461 | Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 0.8 | 2.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 0.8 | 3.1 | GO:2000606 | regulation of cell proliferation involved in mesonephros development(GO:2000606) negative regulation of cell proliferation involved in mesonephros development(GO:2000607) fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000699) glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000701) regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000702) negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000703) regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000733) negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000734) |
| 0.8 | 2.3 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.8 | 3.8 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.7 | 4.4 | GO:0043366 | beta selection(GO:0043366) |
| 0.7 | 1.5 | GO:0070944 | neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.7 | 2.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.7 | 2.2 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
| 0.7 | 1.4 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 0.7 | 1.4 | GO:0002339 | B cell selection(GO:0002339) |
| 0.7 | 4.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.7 | 2.1 | GO:0045553 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
| 0.7 | 2.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.7 | 0.7 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.7 | 3.5 | GO:0002357 | defense response to tumor cell(GO:0002357) |
| 0.7 | 4.9 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 0.7 | 2.1 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.7 | 5.5 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.7 | 2.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
| 0.7 | 2.0 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.7 | 0.7 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 0.7 | 4.0 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.7 | 3.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.7 | 5.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.7 | 3.9 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.6 | 1.9 | GO:2000506 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) negative regulation of energy homeostasis(GO:2000506) |
| 0.6 | 1.9 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 0.6 | 1.3 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.6 | 2.5 | GO:0050823 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.6 | 5.1 | GO:0035696 | monocyte extravasation(GO:0035696) |
| 0.6 | 2.5 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 0.6 | 6.3 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.6 | 3.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.6 | 2.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 | 1.8 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.6 | 4.2 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.6 | 1.2 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
| 0.6 | 2.9 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.6 | 1.7 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.6 | 5.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.6 | 5.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.6 | 4.0 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.6 | 0.6 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.6 | 2.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.5 | 4.4 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.5 | 2.2 | GO:0051413 | response to cortisone(GO:0051413) |
| 0.5 | 2.2 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.5 | 2.2 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 0.5 | 2.2 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.5 | 2.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 0.5 | 1.1 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.5 | 1.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 0.5 | 4.7 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.5 | 1.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.5 | 2.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.5 | 0.5 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 0.5 | 5.0 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.5 | 9.8 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.5 | 7.4 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.5 | 1.5 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.5 | 3.9 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.5 | 2.4 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.5 | 4.4 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.5 | 8.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.5 | 46.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.5 | 4.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.5 | 2.4 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
| 0.5 | 2.4 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.5 | 3.3 | GO:0010266 | response to vitamin B1(GO:0010266) |
| 0.5 | 1.4 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.5 | 0.9 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.5 | 1.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.5 | 0.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 0.4 | 1.8 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.4 | 0.4 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
| 0.4 | 4.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.4 | 4.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.4 | 1.8 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.4 | 3.5 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.4 | 4.0 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 | 1.8 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.4 | 6.2 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.4 | 0.9 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
| 0.4 | 2.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.4 | 3.0 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.4 | 1.3 | GO:1901804 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 0.4 | 16.8 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) |
| 0.4 | 1.3 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.4 | 6.0 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.4 | 2.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.4 | 1.3 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.4 | 1.3 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.4 | 1.7 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.4 | 1.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.4 | 4.6 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.4 | 8.2 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.4 | 0.8 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
| 0.4 | 4.5 | GO:0048007 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.4 | 2.4 | GO:0050904 | diapedesis(GO:0050904) |
| 0.4 | 1.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.4 | 3.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 0.4 | 2.0 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.4 | 4.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.4 | 1.2 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.4 | 1.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.4 | 5.5 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.4 | 0.8 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.4 | 2.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.4 | 1.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.4 | 2.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.4 | 1.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.4 | 9.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.4 | 74.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.4 | 2.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.4 | 1.5 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.4 | 1.5 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 0.4 | 1.1 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
| 0.4 | 3.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.4 | 1.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.4 | 1.1 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
| 0.4 | 6.2 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.4 | 1.1 | GO:0042946 | glucoside transport(GO:0042946) |
| 0.4 | 1.1 | GO:0034769 | basement membrane disassembly(GO:0034769) |
| 0.4 | 1.8 | GO:2000330 | interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
| 0.4 | 2.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.4 | 22.9 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.4 | 3.9 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 | 3.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.3 | 2.4 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.3 | 1.0 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.3 | 1.0 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.3 | 1.4 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.3 | 2.1 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.3 | 3.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.3 | 1.0 | GO:0060374 | mast cell differentiation(GO:0060374) |
| 0.3 | 3.0 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.3 | 2.4 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.3 | 9.0 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.3 | 1.0 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.3 | 0.3 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.3 | 14.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.3 | 2.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.3 | 0.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.3 | 0.6 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.3 | 1.0 | GO:0032308 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.3 | 0.6 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 0.3 | 0.3 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.3 | 1.0 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.3 | 1.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.3 | 1.0 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.3 | 3.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.3 | 1.3 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.3 | 0.9 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.3 | 0.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.3 | 0.6 | GO:1902263 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.3 | 1.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
| 0.3 | 4.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.3 | 0.9 | GO:0036245 | cellular response to menadione(GO:0036245) |
| 0.3 | 0.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.3 | 0.9 | GO:0042495 | toll-like receptor 1 signaling pathway(GO:0034130) detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 0.3 | 0.6 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.3 | 1.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.3 | 0.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.3 | 1.5 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 39.0 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.3 | 0.9 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.3 | 0.3 | GO:0072554 | blood vessel lumenization(GO:0072554) |
| 0.3 | 3.7 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.3 | 0.9 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.3 | 1.7 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.3 | 0.6 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.3 | 0.6 | GO:0002769 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) natural killer cell inhibitory signaling pathway(GO:0002769) |
| 0.3 | 2.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.3 | 1.1 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 0.3 | 2.8 | GO:0002363 | T-helper cell lineage commitment(GO:0002295) alpha-beta T cell lineage commitment(GO:0002363) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
| 0.3 | 0.8 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.3 | 0.6 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.3 | 0.6 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
| 0.3 | 2.5 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.3 | 11.8 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 0.3 | 0.8 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 0.3 | 1.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 | 0.8 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.3 | 0.5 | GO:0042710 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.3 | 3.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.3 | 1.9 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.3 | 2.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.3 | 1.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 0.3 | 0.8 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.3 | 1.9 | GO:0090096 | regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.3 | 0.8 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.3 | 0.8 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.3 | 0.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.3 | 1.3 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 0.3 | 2.9 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.3 | 1.1 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.3 | 0.3 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.3 | 1.1 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.3 | 10.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.3 | 1.1 | GO:0085032 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.3 | 0.5 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.3 | 1.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.3 | 2.1 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.3 | 5.7 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 | 0.8 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.3 | 0.3 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.3 | 1.3 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 0.3 | 1.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.3 | 1.0 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 | 1.0 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.3 | 0.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.2 | 3.0 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
| 0.2 | 0.2 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.2 | 0.7 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.2 | 2.7 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.2 | 1.0 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 0.2 | 2.2 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.2 | 2.4 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.2 | 4.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.2 | 1.4 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
| 0.2 | 0.5 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.2 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 | 0.7 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.2 | 0.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.2 | 0.7 | GO:0061182 | negative regulation of chondrocyte development(GO:0061182) |
| 0.2 | 1.6 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
| 0.2 | 5.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.2 | 0.5 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
| 0.2 | 2.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 | 0.9 | GO:0010446 | response to alkaline pH(GO:0010446) |
| 0.2 | 3.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.2 | 1.4 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.2 | 2.3 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 | 0.7 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 0.4 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.2 | 0.2 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
| 0.2 | 11.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.2 | 1.6 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.2 | 0.7 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 1.1 | GO:0051708 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.2 | 0.2 | GO:1905073 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.2 | 0.7 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 | 0.9 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.2 | 2.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 1.1 | GO:0045007 | depurination(GO:0045007) |
| 0.2 | 1.7 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.2 | 2.1 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.2 | 3.6 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.2 | 2.7 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 0.2 | 2.9 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.8 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.2 | 2.3 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.2 | 3.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 | 5.4 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.2 | 0.4 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.2 | 2.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 2.3 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.2 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.2 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.2 | 0.6 | GO:0042488 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) positive regulation of enamel mineralization(GO:0070175) |
| 0.2 | 0.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 0.2 | GO:0060067 | cervix development(GO:0060067) |
| 0.2 | 145.6 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.2 | 0.2 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) |
| 0.2 | 1.0 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.2 | 0.6 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 0.8 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 | 0.6 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.2 | 1.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 | 0.8 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.2 | 0.6 | GO:0015734 | taurine transport(GO:0015734) |
| 0.2 | 0.6 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.2 | 0.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 0.2 | 1.7 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 | 1.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.2 | 0.8 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 | 0.4 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.2 | 3.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.2 | 3.9 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.2 | 2.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.2 | 0.7 | GO:1900148 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.2 | 0.6 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 | 1.7 | GO:0015840 | urea transport(GO:0015840) |
| 0.2 | 4.4 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.2 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
| 0.2 | 1.6 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.2 | 0.4 | GO:0035624 | receptor transactivation(GO:0035624) |
| 0.2 | 0.9 | GO:0034414 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
| 0.2 | 0.4 | GO:1990668 | vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.2 | 1.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 | 2.9 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.2 | 1.6 | GO:0002507 | tolerance induction(GO:0002507) |
| 0.2 | 1.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 | 2.3 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
| 0.2 | 0.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.2 | 1.1 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.2 | 0.4 | GO:0071314 | cellular response to cocaine(GO:0071314) |
| 0.2 | 1.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.2 | 2.2 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 1.7 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 | 2.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.2 | 0.7 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 0.2 | 0.5 | GO:0030035 | microspike assembly(GO:0030035) |
| 0.2 | 0.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.2 | 0.3 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
| 0.2 | 1.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.2 | 3.6 | GO:0015816 | glycine transport(GO:0015816) |
| 0.2 | 1.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.2 | 1.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.2 | 0.3 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 | 0.5 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
| 0.2 | 4.5 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 1.0 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.2 | 1.0 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.2 | 0.2 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.2 | 0.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 | 1.1 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.2 | 0.6 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.2 | 9.3 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.2 | 3.7 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
| 0.2 | 0.2 | GO:1902869 | regulation of amacrine cell differentiation(GO:1902869) |
| 0.2 | 1.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.2 | 2.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.2 | 0.9 | GO:0001554 | luteolysis(GO:0001554) |
| 0.2 | 0.3 | GO:0018963 | phthalate metabolic process(GO:0018963) |
| 0.2 | 0.5 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.2 | 0.5 | GO:2001311 | lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.2 | 0.5 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.2 | 0.8 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.2 | 1.2 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.2 | 1.2 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.2 | 0.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.2 | 1.8 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.2 | 1.1 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 | 2.1 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.1 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 1.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 | 2.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.1 | 0.7 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 0.1 | 2.4 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 0.1 | 0.7 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 1.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.1 | 2.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 | 0.7 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.1 | 0.3 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 | 0.4 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 0.1 | 0.4 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.1 | 0.7 | GO:0060068 | vagina development(GO:0060068) |
| 0.1 | 0.7 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.1 | 0.8 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.1 | 0.6 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.1 | 0.4 | GO:0090222 | centrosome-templated microtubule nucleation(GO:0090222) |
| 0.1 | 0.3 | GO:0035565 | regulation of pronephros size(GO:0035565) |
| 0.1 | 9.7 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 0.1 | 0.1 | GO:0035627 | ceramide transport(GO:0035627) |
| 0.1 | 1.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 | 0.3 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.1 | 20.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.3 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
| 0.1 | 0.4 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 | 0.8 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 1.8 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 | 0.1 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
| 0.1 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.7 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 | 1.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 | 0.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.1 | 0.8 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 | 0.7 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 | 8.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 | 2.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.5 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
| 0.1 | 0.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
| 0.1 | 0.4 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 | 2.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.4 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 0.1 | 0.9 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 0.8 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.1 | 0.3 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.6 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.1 | 2.0 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.5 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.1 | 0.3 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.1 | 1.0 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.1 | 0.9 | GO:0045576 | mast cell activation(GO:0045576) |
| 0.1 | 2.6 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.1 | 1.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 0.7 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.1 | 0.6 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.1 | 0.4 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) negative regulation of gap junction assembly(GO:1903597) |
| 0.1 | 0.6 | GO:0033384 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.1 | 2.1 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
| 0.1 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 | 0.7 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.6 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 | 2.8 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
| 0.1 | 0.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.1 | 0.4 | GO:0006683 | galactosylceramide catabolic process(GO:0006683) |
| 0.1 | 0.5 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.1 | 0.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
| 0.1 | 0.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
| 0.1 | 0.9 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
| 0.1 | 0.2 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.1 | 1.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.3 | GO:1902990 | mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 | 1.0 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
| 0.1 | 0.9 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.1 | 0.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 0.5 | GO:0040040 | thermosensory behavior(GO:0040040) |
| 0.1 | 0.1 | GO:0036035 | osteoclast development(GO:0036035) |
| 0.1 | 0.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 0.6 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.1 | 1.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 0.1 | 4.6 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.1 | 0.2 | GO:0072179 | nephric duct formation(GO:0072179) |
| 0.1 | 0.3 | GO:0036451 | cap mRNA methylation(GO:0036451) |
| 0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.1 | 0.9 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.1 | 0.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.1 | 0.4 | GO:0033037 | polysaccharide localization(GO:0033037) |
| 0.1 | 1.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.1 | 0.3 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.1 | 1.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 2.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 0.3 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
| 0.1 | 2.8 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 0.5 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
| 0.1 | 2.4 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 | 0.4 | GO:0000019 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
| 0.1 | 0.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 0.7 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 0.1 | 1.6 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
| 0.1 | 0.6 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 | 0.6 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 | 1.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.1 | 0.3 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 0.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.1 | 0.3 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 | 0.4 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 | 1.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 | 1.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.3 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) telomere maintenance via base-excision repair(GO:0097698) |
| 0.1 | 0.8 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 | 0.3 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.1 | 0.5 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
| 0.1 | 0.7 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 1.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 1.6 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.1 | 0.5 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.1 | 0.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 | 0.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
| 0.1 | 0.5 | GO:0038016 | insulin receptor internalization(GO:0038016) |
| 0.1 | 0.4 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.1 | 0.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 | 2.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.1 | 0.8 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.1 | 1.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 0.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 1.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 0.9 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.1 | 2.2 | GO:0006555 | methionine metabolic process(GO:0006555) |
| 0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.1 | 0.5 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 0.1 | 0.3 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.1 | 0.2 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.1 | 0.4 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
| 0.1 | 0.3 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.1 | 0.6 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.1 | 0.6 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.7 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 0.3 | GO:0097086 | amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 0.1 | 1.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.1 | 0.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.9 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.1 | 0.2 | GO:0032258 | CVT pathway(GO:0032258) |
| 0.1 | 0.6 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.1 | 0.3 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.1 | 0.9 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 0.3 | GO:0060431 | primary lung bud formation(GO:0060431) |
| 0.1 | 0.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.1 | 0.5 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.3 | GO:0010983 | regulation of high-density lipoprotein particle clearance(GO:0010982) positive regulation of high-density lipoprotein particle clearance(GO:0010983) positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.1 | 2.4 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.7 | GO:0002675 | positive regulation of acute inflammatory response(GO:0002675) |
| 0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 | 0.2 | GO:0002467 | germinal center formation(GO:0002467) |
| 0.1 | 0.3 | GO:0098502 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) DNA dephosphorylation(GO:0098502) DNA 3' dephosphorylation(GO:0098503) DNA 3' dephosphorylation involved in DNA repair(GO:0098504) polynucleotide 3' dephosphorylation(GO:0098506) |
| 0.1 | 0.1 | GO:1904798 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
| 0.1 | 0.3 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.1 | 0.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 0.1 | 2.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.1 | 0.5 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 | 0.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.3 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 | 0.3 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 | 2.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 0.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 0.2 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
| 0.1 | 0.7 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 | 1.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 0.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.1 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 0.4 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 | 0.5 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.1 | 0.7 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 | 1.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.1 | 12.1 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.1 | 0.8 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.1 | 0.2 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.1 | 0.4 | GO:1904744 | regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
| 0.1 | 0.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.1 | 0.2 | GO:1903936 | cellular response to sodium arsenite(GO:1903936) |
| 0.1 | 0.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.1 | 0.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.4 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 | 0.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 | 0.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.1 | 0.4 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
| 0.1 | 0.2 | GO:0046041 | ITP metabolic process(GO:0046041) |
| 0.1 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 | 1.3 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.1 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 0.3 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
| 0.1 | 0.3 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 0.1 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.1 | 0.2 | GO:0055099 | detection of hormone stimulus(GO:0009720) response to high density lipoprotein particle(GO:0055099) |
| 0.1 | 10.5 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
| 0.1 | 1.0 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
| 0.1 | 0.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 0.5 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 0.9 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
| 0.1 | 1.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 1.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.1 | 1.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 1.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.1 | 3.7 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
| 0.1 | 0.8 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.1 | 0.7 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.1 | 1.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.1 | 0.2 | GO:0006463 | steroid hormone receptor complex assembly(GO:0006463) |
| 0.1 | 0.4 | GO:0032202 | telomere assembly(GO:0032202) |
| 0.1 | 0.8 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 0.7 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 0.1 | 1.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 | 0.2 | GO:0021561 | facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
| 0.1 | 0.1 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 | 0.1 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
| 0.1 | 1.6 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 | 0.5 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.1 | 0.1 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.1 | 1.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.1 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.1 | 2.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 0.4 | GO:0070378 | regulation of ERK5 cascade(GO:0070376) positive regulation of ERK5 cascade(GO:0070378) |
| 0.1 | 0.2 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 0.1 | 2.6 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.1 | 0.6 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 0.3 | GO:0043144 | snoRNA processing(GO:0043144) |
| 0.1 | 0.3 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.1 | 0.3 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.1 | 0.1 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.4 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
| 0.1 | 0.3 | GO:0006233 | dUDP biosynthetic process(GO:0006227) dTDP biosynthetic process(GO:0006233) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dTDP metabolic process(GO:0046072) dUDP metabolic process(GO:0046077) |
| 0.1 | 0.6 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 1.3 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 | 1.1 | GO:0002449 | lymphocyte mediated immunity(GO:0002449) |
| 0.1 | 2.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
| 0.1 | 0.7 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.3 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.1 | 1.7 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.1 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 | 0.5 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.1 | 0.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.1 | 0.5 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 0.9 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.1 | 0.4 | GO:0097398 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 0.5 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 | 0.2 | GO:0090260 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.1 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 | 2.3 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.1 | 1.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.1 | 0.7 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 | 0.5 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) |
| 0.1 | 0.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.2 | GO:0021593 | rhombomere morphogenesis(GO:0021593) rhombomere 3 morphogenesis(GO:0021658) |
| 0.1 | 8.6 | GO:0006909 | phagocytosis(GO:0006909) |
| 0.1 | 0.5 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.1 | 0.4 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 | 3.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 0.5 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.1 | 0.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
| 0.1 | 0.8 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
| 0.1 | 1.0 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.1 | 0.3 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.1 | 0.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.1 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.1 | 0.1 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
| 0.1 | 2.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.1 | 0.7 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 0.3 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.6 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 4.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.1 | 0.8 | GO:0034695 | response to prostaglandin E(GO:0034695) |
| 0.1 | 0.9 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
| 0.1 | 3.8 | GO:0010965 | regulation of mitotic sister chromatid separation(GO:0010965) |
| 0.1 | 0.2 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 | 0.4 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.2 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.1 | 0.4 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 0.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.1 | 0.3 | GO:2001271 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.4 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
| 0.1 | 1.0 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.1 | 0.3 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 0.2 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 1.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.1 | 0.2 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.1 | 0.2 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
| 0.1 | 2.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 | 0.1 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.1 | 0.5 | GO:0006559 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 2.5 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.1 | 0.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 3.2 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.1 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 | 0.7 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.0 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.0 | 0.9 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.0 | 0.3 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.0 | 0.1 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.0 | 0.1 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 | 0.3 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
| 0.0 | 0.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.0 | 0.9 | GO:0071435 | potassium ion export(GO:0071435) |
| 0.0 | 0.2 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 0.0 | 0.2 | GO:0070893 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.0 | 0.5 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.0 | 0.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 | 0.3 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.0 | 0.1 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.0 | 1.0 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.0 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.0 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.0 | 0.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 0.0 | 0.2 | GO:0033306 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.0 | 0.3 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.0 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.0 | 0.1 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.0 | 1.4 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.0 | 0.1 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.0 | 2.4 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.0 | 0.2 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 | 0.7 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
| 0.0 | 0.6 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.0 | 0.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 0.0 | 0.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.0 | 1.2 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.0 | 0.6 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.0 | 0.5 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.0 | 0.2 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 | 0.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.0 | 0.1 | GO:0021551 | central nervous system morphogenesis(GO:0021551) |
| 0.0 | 0.4 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.0 | 0.0 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.0 | 0.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.0 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.0 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.0 | 0.2 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 0.0 | 0.7 | GO:0048730 | epidermis morphogenesis(GO:0048730) |
| 0.0 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 | 0.3 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.0 | 0.1 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 0.1 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.0 | 0.0 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
| 0.0 | 0.1 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.0 | 0.3 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.0 | 0.1 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.0 | 0.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.0 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 | 0.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.0 | 0.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 | 0.2 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 0.0 | 0.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 | 0.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 | 0.5 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 | 0.1 | GO:1904732 | regulation of electron carrier activity(GO:1904732) |
| 0.0 | 0.4 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.0 | 0.1 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 | 0.4 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.0 | 0.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.0 | 0.3 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.0 | 1.4 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 | 0.9 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.0 | 0.5 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.0 | 0.1 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.0 | 0.2 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.0 | 0.3 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 | 1.1 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.0 | 0.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.2 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.0 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.0 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 18.4 | GO:0006955 | immune response(GO:0006955) |
| 0.0 | 0.7 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.0 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.0 | 0.1 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
| 0.0 | 0.0 | GO:0070627 | ferrous iron transport(GO:0015684) ferrous iron import(GO:0070627) ferrous iron transmembrane transport(GO:1903874) |
| 0.0 | 0.1 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.0 | 0.6 | GO:0097369 | sodium ion import(GO:0097369) |
| 0.0 | 0.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.0 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 | 0.7 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.0 | 0.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.0 | 0.2 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
| 0.0 | 0.1 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.0 | 0.7 | GO:0050870 | positive regulation of T cell activation(GO:0050870) |
| 0.0 | 0.1 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) telomere maintenance in response to DNA damage(GO:0043247) |
| 0.0 | 0.3 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.0 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.1 | GO:0046219 | indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.0 | 0.4 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
| 0.0 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.0 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.0 | 0.4 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
| 0.0 | 0.3 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.0 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.0 | 0.7 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.0 | 0.6 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.0 | 0.7 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.0 | 0.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.0 | 1.7 | GO:0007602 | phototransduction(GO:0007602) |
| 0.0 | 0.1 | GO:0043476 | pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) |
| 0.0 | 0.1 | GO:0071962 | mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.0 | 0.0 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
| 0.0 | 0.6 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 0.0 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
| 0.0 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.6 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.0 | 0.0 | GO:0050720 | interleukin-1 biosynthetic process(GO:0042222) interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.0 | 0.1 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.0 | 0.5 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.0 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.0 | 0.6 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.0 | 1.1 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.2 | GO:0021548 | pons development(GO:0021548) |
| 0.0 | 0.1 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.0 | 0.5 | GO:0046931 | pore complex assembly(GO:0046931) |
| 0.0 | 0.0 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.0 | 0.1 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.0 | 0.2 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 | 0.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.0 | 0.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
| 0.0 | 0.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.0 | 0.1 | GO:0019542 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate biosynthetic process(GO:0019542) |
| 0.0 | 0.1 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.0 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
| 0.0 | 0.1 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.0 | 0.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.0 | 0.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.0 | 0.2 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.0 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 | 0.3 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.0 | 0.3 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.1 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.0 | 0.0 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 | 0.1 | GO:0071941 | urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
| 0.0 | 0.5 | GO:0002697 | regulation of immune effector process(GO:0002697) |
| 0.0 | 0.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.0 | 0.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.0 | 2.0 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
| 0.0 | 0.1 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.0 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 0.0 | 0.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.0 | 0.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.0 | 0.0 | GO:0042256 | mature ribosome assembly(GO:0042256) |
| 0.0 | 0.0 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.0 | 0.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.0 | 0.1 | GO:0042148 | strand invasion(GO:0042148) |
| 0.0 | 0.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.0 | 0.4 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 | 0.3 | GO:0071219 | cellular response to molecule of bacterial origin(GO:0071219) |
| 0.0 | 0.1 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 | 0.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 | 0.2 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.0 | 0.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.0 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.0 | 0.1 | GO:0060613 | fat pad development(GO:0060613) |
| 0.0 | 0.1 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.0 | 0.1 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 0.0 | 0.1 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.0 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
| 0.0 | 0.1 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.0 | 0.1 | GO:0000732 | strand displacement(GO:0000732) |
| 0.0 | 0.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.0 | 0.1 | GO:0010324 | membrane invagination(GO:0010324) |
| 0.0 | 0.4 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 | 0.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.2 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.6 | 26.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 2.4 | 142.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 2.4 | 7.1 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 1.5 | 7.6 | GO:0019814 | immunoglobulin complex(GO:0019814) |
| 1.5 | 6.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 1.5 | 4.5 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
| 1.3 | 14.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 1.2 | 23.5 | GO:0042611 | MHC protein complex(GO:0042611) |
| 1.2 | 38.0 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 1.1 | 6.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 1.0 | 9.6 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.9 | 0.9 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.9 | 6.9 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.8 | 5.7 | GO:1990031 | pinceau fiber(GO:1990031) |
| 0.8 | 2.3 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 0.8 | 3.8 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.7 | 3.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.7 | 8.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.7 | 6.1 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.7 | 16.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.6 | 3.7 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.6 | 1.8 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.5 | 3.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.5 | 2.2 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.5 | 2.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.5 | 35.0 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.5 | 3.7 | GO:0070876 | SOSS complex(GO:0070876) |
| 0.5 | 5.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.5 | 5.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.5 | 1.9 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.5 | 5.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.5 | 63.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.4 | 3.0 | GO:0042825 | TAP complex(GO:0042825) |
| 0.4 | 8.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 1.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.4 | 2.4 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.4 | 1.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.4 | 5.3 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.4 | 0.7 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.4 | 1.8 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.4 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.3 | 2.4 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.3 | 1.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.3 | 2.7 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.3 | 5.0 | GO:0097413 | Lewy body(GO:0097413) |
| 0.3 | 9.6 | GO:0042627 | chylomicron(GO:0042627) |
| 0.3 | 49.2 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.3 | 1.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.3 | 2.5 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.3 | 2.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.3 | 1.2 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.3 | 0.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.3 | 0.9 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.3 | 10.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 0.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.3 | 0.8 | GO:0000805 | X chromosome(GO:0000805) |
| 0.3 | 1.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.3 | 0.8 | GO:0090651 | apical cytoplasm(GO:0090651) |
| 0.3 | 2.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.3 | 0.3 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.3 | 5.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.3 | 5.3 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 21.9 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.3 | 2.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.3 | 2.0 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.2 | 1.5 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.2 | 0.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.2 | 1.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.2 | 0.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.2 | 5.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 3.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 21.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 0.9 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.2 | 40.2 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.2 | 2.9 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 1.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 7.6 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.2 | 72.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.2 | 12.2 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.2 | 1.2 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 1.0 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.2 | 0.8 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 0.6 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.2 | 1.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.2 | 0.8 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
| 0.2 | 0.6 | GO:0033597 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.2 | 1.3 | GO:1990462 | omegasome(GO:1990462) |
| 0.2 | 0.7 | GO:1990879 | CST complex(GO:1990879) |
| 0.2 | 6.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 1.0 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.2 | 0.7 | GO:0097196 | Shu complex(GO:0097196) |
| 0.2 | 1.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.2 | 0.6 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.2 | 0.2 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.2 | 0.5 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.2 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.2 | 1.1 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 0.2 | 0.8 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.1 | 0.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 2.1 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.1 | 0.9 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.1 | 1.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.1 | 2.7 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.1 | 3.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.1 | 16.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 2.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.1 | 1.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.1 | 1.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 0.1 | 10.2 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.2 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.1 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.4 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.1 | 3.3 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.5 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.1 | 2.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.6 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.1 | 1.2 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 0.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.1 | 0.2 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 2.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 1.8 | GO:0005767 | secondary lysosome(GO:0005767) |
| 0.1 | 4.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.1 | 0.6 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.1 | 0.7 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 19.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.1 | 1.5 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 0.3 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.1 | 0.7 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 3.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 12.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 0.7 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 0.3 | GO:0070877 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.1 | 0.3 | GO:1990435 | stereocilia tip link(GO:0002140) myosin VII complex(GO:0031477) stereocilia tip-link density(GO:1990427) upper tip-link density(GO:1990435) |
| 0.1 | 1.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 2.0 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 6.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 0.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.1 | 0.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 1.6 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.1 | 0.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.1 | 2.4 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 2.9 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.1 | 2.5 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 0.6 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.2 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.1 | 0.2 | GO:0031251 | PAN complex(GO:0031251) |
| 0.1 | 0.5 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.2 | GO:0060342 | photoreceptor inner segment membrane(GO:0060342) |
| 0.1 | 0.4 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 0.8 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
| 0.1 | 0.7 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.1 | 0.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
| 0.1 | 0.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.1 | 24.9 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.1 | 1.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 3.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.1 | GO:0042599 | lamellar body(GO:0042599) |
| 0.1 | 5.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.1 | 0.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.1 | 1.4 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.1 | 3.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.1 | 0.3 | GO:0005726 | perichromatin fibrils(GO:0005726) |
| 0.1 | 0.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.1 | 0.9 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.1 | 0.2 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.1 | 0.6 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 7.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 1.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.4 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 0.9 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 0.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 3.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 0.1 | GO:0044453 | nuclear membrane part(GO:0044453) |
| 0.1 | 1.1 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.2 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.1 | 12.3 | GO:0034774 | secretory granule lumen(GO:0034774) |
| 0.1 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
| 0.1 | 0.2 | GO:0072517 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.1 | 1.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 0.4 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.2 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.1 | 1.2 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.1 | 4.2 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.1 | 1.3 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 0.9 | GO:0045120 | pronucleus(GO:0045120) |
| 0.1 | 0.7 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
| 0.1 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.0 | 0.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.0 | 1.0 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.0 | 1.2 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 0.2 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.0 | 0.5 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
| 0.0 | 0.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.0 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 3.7 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 0.3 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.0 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.0 | 2.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.0 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.0 | 0.2 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.0 | 0.2 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
| 0.0 | 0.1 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.0 | 0.2 | GO:0035363 | histone locus body(GO:0035363) |
| 0.0 | 66.5 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.0 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 0.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.0 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.0 | 1.4 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
| 0.0 | 0.4 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.0 | 0.8 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.0 | 0.4 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.0 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 0.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 5.0 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 0.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.0 | 0.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.0 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.0 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.0 | 0.5 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.0 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.0 | 1.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.0 | 0.7 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 13.6 | GO:0000790 | nuclear chromatin(GO:0000790) |
| 0.0 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.0 | 0.1 | GO:0070470 | plasma membrane respiratory chain complex I(GO:0045272) plasma membrane respiratory chain(GO:0070470) |
| 0.0 | 0.2 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.0 | 0.1 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.0 | 0.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.0 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.0 | 3.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.0 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.0 | 0.6 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.0 | 0.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.0 | 2.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.0 | 0.5 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.1 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.0 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.0 | 0.2 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.0 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
| 0.0 | 0.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
| 0.0 | 0.1 | GO:0098536 | deuterosome(GO:0098536) |
| 0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.0 | 1.4 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
| 0.0 | 0.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 0.2 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.0 | GO:0005816 | spindle pole body(GO:0005816) |
| 0.0 | 0.0 | GO:0044393 | microspike(GO:0044393) |
| 0.0 | 0.1 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.0 | 0.2 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 14.7 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 2.7 | 8.1 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
| 2.6 | 7.9 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 2.6 | 28.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 2.3 | 6.9 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 2.0 | 141.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 1.9 | 15.4 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 1.5 | 4.4 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 1.4 | 25.3 | GO:0019864 | IgG binding(GO:0019864) |
| 1.3 | 4.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
| 1.3 | 5.3 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 1.3 | 3.8 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 1.2 | 262.5 | GO:0003823 | antigen binding(GO:0003823) |
| 1.2 | 2.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
| 1.2 | 3.6 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 1.2 | 3.5 | GO:0004411 | homogentisate 1,2-dioxygenase activity(GO:0004411) |
| 1.1 | 6.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 1.1 | 4.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 1.1 | 5.5 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 1.1 | 4.4 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.1 | 9.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.1 | 5.3 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 1.1 | 3.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 1.0 | 3.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
| 1.0 | 16.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 1.0 | 2.9 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 0.9 | 4.7 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 0.9 | 7.3 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.9 | 3.7 | GO:0019862 | IgA binding(GO:0019862) |
| 0.9 | 7.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.9 | 2.7 | GO:0004500 | dopamine beta-monooxygenase activity(GO:0004500) |
| 0.9 | 20.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.9 | 7.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.8 | 2.5 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.8 | 11.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.8 | 10.5 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.8 | 2.4 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.8 | 2.4 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.8 | 3.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.8 | 3.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.7 | 2.2 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
| 0.7 | 4.3 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.7 | 11.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.7 | 6.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.7 | 2.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.7 | 2.0 | GO:0032428 | sphingolipid activator protein activity(GO:0030290) beta-N-acetylgalactosaminidase activity(GO:0032428) |
| 0.6 | 4.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.6 | 1.9 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.6 | 6.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.6 | 3.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.6 | 1.9 | GO:0000247 | C-8 sterol isomerase activity(GO:0000247) cholestenol delta-isomerase activity(GO:0047750) |
| 0.6 | 3.2 | GO:0034875 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.6 | 2.5 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
| 0.6 | 1.8 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
| 0.6 | 3.6 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.6 | 3.0 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.6 | 1.8 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
| 0.6 | 1.8 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.6 | 0.6 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.6 | 3.9 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
| 0.6 | 2.8 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
| 0.5 | 3.8 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.5 | 2.7 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.5 | 9.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.5 | 2.6 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.5 | 1.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.5 | 2.6 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.5 | 1.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.5 | 7.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.5 | 4.5 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 0.5 | 2.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.5 | 26.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.5 | 1.5 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.5 | 3.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.5 | 2.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.5 | 1.4 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.5 | 1.9 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.5 | 2.4 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.5 | 3.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.5 | 1.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 0.5 | 1.4 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.5 | 1.4 | GO:0043739 | G/U mismatch-specific uracil-DNA glycosylase activity(GO:0043739) |
| 0.4 | 1.8 | GO:0001626 | nociceptin receptor activity(GO:0001626) |
| 0.4 | 2.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.4 | 3.1 | GO:0042806 | fucose binding(GO:0042806) |
| 0.4 | 1.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.4 | 0.4 | GO:0023029 | peptide antigen-transporting ATPase activity(GO:0015433) MHC class Ib protein binding(GO:0023029) |
| 0.4 | 2.1 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.4 | 1.6 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.4 | 2.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.4 | 1.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.4 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.4 | 4.8 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.4 | 1.2 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.4 | 2.4 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.4 | 1.2 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 0.4 | 2.4 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.4 | 2.0 | GO:0002054 | nucleobase binding(GO:0002054) |
| 0.4 | 1.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.4 | 1.6 | GO:0070224 | sulfide:quinone oxidoreductase activity(GO:0070224) |
| 0.4 | 5.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.4 | 3.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.4 | 1.9 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
| 0.4 | 1.9 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.4 | 1.5 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.4 | 1.5 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.4 | 1.1 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 0.4 | 2.6 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.4 | 2.6 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.4 | 1.8 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.4 | 8.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.4 | 1.1 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 0.4 | 1.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.4 | 1.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.4 | 4.6 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.4 | 1.8 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.3 | 2.4 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.3 | 3.0 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.3 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.3 | 3.0 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 1.0 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.3 | 5.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.3 | 1.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.3 | 0.7 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.3 | 2.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.3 | 1.6 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.3 | 1.2 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.3 | 0.3 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.3 | 2.1 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.3 | 3.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.3 | 5.6 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.3 | 2.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.3 | 1.2 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.3 | 6.1 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.3 | 12.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.3 | 1.1 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
| 0.3 | 5.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.3 | 3.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.3 | 2.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.3 | 0.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 0.3 | 1.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 0.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.3 | 27.8 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.3 | 1.6 | GO:0050436 | microfibril binding(GO:0050436) |
| 0.3 | 2.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.3 | 1.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.3 | 1.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.3 | 2.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.3 | 0.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.3 | 1.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.3 | 0.8 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.3 | 1.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.3 | 0.8 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.3 | 1.0 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.2 | 5.0 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.2 | 0.7 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 3.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.2 | 1.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.2 | 1.0 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 0.2 | 3.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.2 | 3.9 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 1.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 0.2 | 7.7 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.2 | 1.0 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.2 | 0.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.2 | 0.7 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.2 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.2 | 0.5 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.2 | 1.9 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.2 | 0.7 | GO:0004577 | N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity(GO:0004577) |
| 0.2 | 2.3 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 0.9 | GO:0002046 | opsin binding(GO:0002046) |
| 0.2 | 0.9 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.2 | 0.7 | GO:0016794 | guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity(GO:0008893) diphosphoric monoester hydrolase activity(GO:0016794) |
| 0.2 | 1.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.2 | 0.9 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.2 | 0.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.2 | 2.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 1.1 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.2 | 3.6 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.2 | 1.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.2 | 0.9 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.2 | 4.7 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.2 | 1.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.2 | 1.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.2 | 0.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.2 | 0.7 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
| 0.2 | 1.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.2 | 0.9 | GO:0004335 | galactokinase activity(GO:0004335) |
| 0.2 | 1.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 3.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.2 | 1.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.2 | 0.6 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.2 | 3.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.2 | 0.8 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.2 | 0.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.2 | 2.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 2.1 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.2 | 1.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 0.2 | 2.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.2 | 20.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.2 | 0.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.2 | 0.8 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.2 | 5.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.2 | 1.2 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.2 | 10.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 0.6 | GO:0005534 | galactose binding(GO:0005534) |
| 0.2 | 3.0 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.2 | 1.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.2 | 0.6 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.2 | 0.6 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.2 | 0.6 | GO:0005368 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
| 0.2 | 2.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.2 | 0.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.2 | 0.6 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.2 | 0.8 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.2 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 0.4 | GO:0005151 | interleukin-1, Type II receptor binding(GO:0005151) |
| 0.2 | 22.1 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 1.5 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
| 0.2 | 0.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.2 | 0.9 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.2 | 1.6 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.2 | 3.0 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 0.9 | GO:0004803 | transposase activity(GO:0004803) |
| 0.2 | 0.7 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
| 0.2 | 1.0 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.2 | 27.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.2 | 12.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.2 | 0.5 | GO:0052852 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.2 | 3.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.2 | 2.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.2 | 4.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.2 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.2 | 0.5 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.2 | 7.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.2 | 13.9 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
| 0.2 | 1.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 0.5 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
| 0.2 | 0.6 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.2 | 1.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.2 | 1.4 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 0.6 | GO:0050473 | linoleate 13S-lipoxygenase activity(GO:0016165) arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.2 | 2.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 1.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.2 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 0.2 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
| 0.2 | 0.5 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.2 | 0.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.2 | 5.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 0.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.2 | 1.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.2 | 5.2 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.2 | 0.9 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.2 | 3.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.2 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 0.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.2 | 1.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.1 | 0.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 0.1 | 4.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 3.7 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.1 | 3.1 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.1 | 1.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.6 | GO:0035671 | enone reductase activity(GO:0035671) |
| 0.1 | 1.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 0.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
| 0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.1 | 4.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.1 | 0.4 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.1 | 0.6 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
| 0.1 | 1.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.1 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.1 | 1.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 0.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.1 | 2.5 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.6 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.1 | 3.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.1 | 1.1 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 3.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.1 | 0.6 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.1 | 2.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.1 | 0.4 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 0.1 | 0.5 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 0.1 | 0.8 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.1 | 1.4 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.1 | 0.5 | GO:0008106 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) alcohol dehydrogenase (NADP+) activity(GO:0008106) |
| 0.1 | 2.1 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.1 | 1.6 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.1 | 0.4 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.1 | 1.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.4 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 2.2 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.1 | 0.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.1 | 0.7 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.1 | 1.7 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 0.4 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.1 | 3.0 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.6 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.1 | 1.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 5.4 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.1 | 0.5 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.1 | 0.6 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.1 | 0.6 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.1 | 0.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.1 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 0.4 | GO:0004040 | amidase activity(GO:0004040) |
| 0.1 | 0.4 | GO:0004336 | galactosylceramidase activity(GO:0004336) |
| 0.1 | 0.8 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 0.5 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.1 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.1 | 1.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.1 | 0.7 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.1 | 1.1 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.1 | 0.2 | GO:0000701 | purine-specific mismatch base pair DNA N-glycosylase activity(GO:0000701) |
| 0.1 | 0.5 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.2 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.1 | 2.5 | GO:0005351 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.1 | 1.0 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.1 | 7.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.1 | 0.7 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.1 | 2.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 1.7 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.1 | 0.3 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
| 0.1 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.4 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
| 0.1 | 1.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 2.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 0.9 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.4 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 1.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.1 | 0.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 0.1 | 1.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.3 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
| 0.1 | 0.5 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.4 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.1 | 1.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 0.3 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.1 | 0.3 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
| 0.1 | 1.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 1.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.1 | 0.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.8 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.1 | 0.2 | GO:0045142 | triplex DNA binding(GO:0045142) |
| 0.1 | 0.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 1.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.3 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.1 | 0.7 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.1 | 0.5 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 3.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.1 | 1.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.1 | 0.8 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.1 | 0.6 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
| 0.1 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.3 | GO:0046403 | polynucleotide 3'-phosphatase activity(GO:0046403) |
| 0.1 | 3.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.3 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.1 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.1 | 3.8 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 0.3 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
| 0.1 | 0.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.3 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 2.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 3.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 17.0 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.1 | 1.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 0.3 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
| 0.1 | 0.9 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 0.3 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
| 0.1 | 5.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 0.5 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.1 | 0.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.1 | 0.2 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.1 | 0.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
| 0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 1.1 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 0.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
| 0.1 | 0.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.1 | 0.3 | GO:0008311 | double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
| 0.1 | 0.4 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.1 | 0.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.1 | 1.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.1 | 0.5 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.1 | 10.3 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 1.4 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.1 | 0.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 0.2 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.1 | 0.1 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 0.1 | 0.2 | GO:0072545 | tyrosine binding(GO:0072545) |
| 0.1 | 1.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 0.7 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
| 0.1 | 16.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.4 | GO:0030298 | receptor signaling protein tyrosine kinase activator activity(GO:0030298) |
| 0.1 | 0.2 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.1 | 1.7 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.1 | 0.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.1 | 0.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.1 | 0.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 1.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.3 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
| 0.1 | 0.3 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.1 | 0.3 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.1 | 0.1 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 0.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
| 0.1 | 0.8 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.1 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.1 | 2.5 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 0.2 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 0.2 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.1 | 1.8 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.5 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.2 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
| 0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 0.5 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.1 | 0.5 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 0.8 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.1 | 0.6 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.1 | 4.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.2 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
| 0.1 | 0.2 | GO:0050146 | nucleoside phosphotransferase activity(GO:0050146) |
| 0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 1.0 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 0.7 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 1.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.1 | 0.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.1 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.0 | 0.3 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.0 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.0 | 0.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.0 | 0.3 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.0 | 0.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.0 | 17.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 0.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.2 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.0 | 2.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.1 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.0 | 0.1 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.0 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.0 | 1.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.0 | 24.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.0 | 1.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.0 | 0.4 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 0.7 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.0 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.0 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.0 | 4.7 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.0 | 0.2 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.0 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.0 | 0.4 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.0 | 0.1 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.0 | 0.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.0 | 0.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.2 | GO:0009378 | four-way junction helicase activity(GO:0009378) |
| 0.0 | 1.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
| 0.0 | 1.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.0 | 0.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.2 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.0 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.0 | 1.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.0 | 0.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
| 0.0 | 0.1 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
| 0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.0 | 0.3 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
| 0.0 | 0.2 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.0 | 0.3 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.0 | 1.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.0 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.0 | 0.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 0.0 | 1.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 1.0 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.0 | 0.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.0 | 3.6 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.1 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.0 | 4.6 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.4 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
| 0.0 | 0.1 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
| 0.0 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.0 | 1.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.0 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.0 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.0 | 0.7 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.1 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.0 | 3.4 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.0 | 0.3 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.0 | 0.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
| 0.0 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.0 | 8.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.0 | 1.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.0 | 0.2 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.0 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 0.0 | 1.1 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.0 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.0 | 1.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.0 | 1.0 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.1 | GO:0048257 | 3'-flap endonuclease activity(GO:0048257) |
| 0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.1 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.0 | 0.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.0 | 0.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.0 | 0.1 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.0 | 0.1 | GO:0015055 | secretin receptor activity(GO:0015055) |
| 0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 0.2 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.0 | 0.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.0 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.0 | 0.7 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.0 | 0.1 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 0.0 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 12.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.0 | 4.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.0 | 0.5 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.0 | 0.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.0 | 0.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.0 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.0 | 0.8 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.0 | 0.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.0 | 0.3 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 0.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.0 | 0.0 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.0 | 0.2 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.0 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.0 | 0.3 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.0 | 1.0 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.0 | 0.1 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.0 | 0.5 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.0 | 0.2 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 1.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 0.0 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.0 | 0.1 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.0 | 0.1 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.0 | 0.1 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.0 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.0 | 0.0 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
| 0.0 | 0.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.0 | 0.1 | GO:0016882 | phosphoribosylamine-glycine ligase activity(GO:0004637) phosphoribosylformylglycinamidine cyclo-ligase activity(GO:0004641) phosphoribosylglycinamide formyltransferase activity(GO:0004644) cyclo-ligase activity(GO:0016882) |
| 0.0 | 0.1 | GO:0016429 | tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
| 0.0 | 0.0 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.6 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.0 | 0.2 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.0 | 0.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.0 | 0.1 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.0 | 0.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
| 0.0 | 0.1 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.0 | 0.4 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 66.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.7 | 5.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.6 | 75.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.5 | 6.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.5 | 23.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.5 | 20.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.4 | 23.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.4 | 25.7 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.4 | 41.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.4 | 6.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.3 | 3.8 | PID EPO PATHWAY | EPO signaling pathway |
| 0.3 | 16.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.3 | 10.4 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 3.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.3 | 9.1 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 6.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.3 | 8.4 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.3 | 4.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 12.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.2 | 12.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.2 | 0.7 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.2 | 20.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.2 | 3.9 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.2 | 6.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.2 | 6.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.2 | 7.5 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.2 | 8.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.2 | 4.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.2 | 4.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 5.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.1 | 3.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.1 | 4.6 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 2.9 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.1 | 4.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.1 | 4.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 5.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.1 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 3.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.1 | 2.7 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 1.8 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 4.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.1 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 10.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 2.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 1.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 1.8 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.1 | 7.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.1 | 3.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 0.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 0.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.1 | 1.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.1 | 2.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 1.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 1.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 7.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 1.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 0.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.1 | 1.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 4.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.0 | 0.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.0 | 3.4 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.0 | 4.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 1.9 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 3.2 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 4.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.0 | 12.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 4.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.0 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.0 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.0 | 1.6 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 0.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.0 | 3.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.0 | 10.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 0.5 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 0.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.0 | 0.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 3.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.0 | 0.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.0 | 0.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.9 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.0 | 0.5 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.0 | 0.6 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.0 | 0.5 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 0.0 | 0.1 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 3.9 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 17.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 1.6 | 35.0 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 1.4 | 14.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.8 | 83.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.6 | 11.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.6 | 3.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.6 | 3.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.5 | 9.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.5 | 6.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.5 | 2.0 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.5 | 14.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.4 | 7.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.4 | 30.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.4 | 7.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 0.4 | 31.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.4 | 5.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.4 | 1.9 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.4 | 17.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.4 | 42.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
| 0.4 | 13.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 10.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.3 | 9.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.3 | 12.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.3 | 0.6 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.3 | 13.8 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.3 | 3.0 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.3 | 3.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.3 | 7.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.2 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.2 | 2.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.2 | 1.6 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.2 | 12.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.2 | 7.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 6.5 | REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.2 | 1.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 0.2 | 2.5 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.2 | 3.7 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.2 | 6.9 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 0.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.2 | 1.0 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.2 | 4.7 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.2 | 3.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.2 | 0.2 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.2 | 6.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 4.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 1.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 9.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 2.5 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.1 | 22.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 3.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.1 | 3.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 3.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.1 | 1.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.1 | 4.0 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 4.5 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.1 | 3.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 4.8 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.1 | 1.1 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.1 | 2.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.1 | 3.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 3.0 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 2.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.1 | 2.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 2.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
| 0.1 | 0.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.1 | 1.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 1.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 4.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 5.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 2.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 2.6 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.1 | 12.1 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.1 | 0.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 1.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 1.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 1.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.1 | 3.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 1.9 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.1 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 4.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.1 | 3.3 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.1 | 5.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.1 | 11.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 6.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 4.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.1 | 2.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 2.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 1.1 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
| 0.1 | 3.5 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.1 | 0.9 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.1 | 1.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 0.1 | 2.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 1.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 1.5 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.1 | 0.7 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.1 | 0.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 2.2 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 15.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.1 | 0.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 1.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 0.8 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.0 | 0.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
| 0.0 | 0.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 6.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.2 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.2 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.0 | 0.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.4 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
| 0.0 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.0 | 1.1 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.0 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
| 0.0 | 2.3 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 2.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
| 0.0 | 0.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.0 | 0.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 0.3 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.0 | 0.1 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
| 0.0 | 0.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.0 | 4.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.0 | 0.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.0 | 0.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.0 | 2.3 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
| 0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.0 | 7.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.0 | 1.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.0 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.0 | 0.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.0 | 0.2 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
| 0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.0 | 0.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.5 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.0 | 1.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.0 | 0.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 0.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 0.0 | 0.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.0 | 0.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 0.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.0 | 0.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.0 | 0.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.0 | 0.4 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
| 0.0 | 0.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.0 | 0.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.0 | 0.3 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |